Fort Sheridan Advisors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $6.89K | Sell |
|
|||||
|
2025
Q1 | $9.93K | Sell |
|
|||||
|
2024
Q4 | $23.5K | Sell |
|
|||||
|
2024
Q3 | $20K | Buy |
|
|||||
|
2024
Q2 | $7.82K | Sell |
|
|||||
|
2024
Q1 | $14.8K | Sell |
|
|||||
|
2023
Q4 | $14.3K | Sell |
|
|||||
|
2023
Q3 | $32.3K | Sell |
|
|||||
|
2023
Q2 | $86.4K | Buy |
|
|||||
|
2023
Q1 | $102K | Sell |
|
|||||
|
2022
Q4 | $185K | Sell |
|
|||||
|
2022
Q3 | $363K | Sell |
|
|||||
|
2022
Q2 | $308K | Buy |
|
|||||
|
2022
Q1 | $430K | Sell |
|
|||||
|
2021
Q4 | $562K | Sell |
|
|||||
|
2021
Q3 | $692K | Sell |
|
|||||
|
2021
Q2 | $930K | Buy |
|
|||||
|
2021
Q1 | $952K | Buy |
|
|||||
|
2020
Q4 | $1.11M | Buy |
|
|||||
|
2020
Q3 | $582K | Buy |
|
|||||
|
2020
Q2 | $396K | Buy |
|
|||||
|
2020
Q1 | $269K | Buy |
|
|||||
|
2019
Q4 | $232K | Buy |
|
|||||
|
2019
Q3 | $211K | Buy |
|